The latter report on the opposite differential sensitivity may reflect the different breast cancer subtypes in which PIK3CA mutations and PTEN loss usually occur (luminal vs. basal-like, respectively), and the effect of cooperating oncogenic signalling on PI3K/PKB-AKT/mTOR activity in the different subtypes of breast cancer. This evidence concerns the gene MTOR and breast carcinoma.